ADx NeuroSciences
Technologiepark 94
9000 Zwijnaarde
BE
ADx NeuroSciences
Foundation date
16/09/2011
Sector
#Biotechnology - TherapeuticsSubsector
We create tailor-made antibodies and assays to quantify unique biomarkers in a wide variety of neurodegenerative diseases and conditions such as Alzheimer’s disease, Parkinson’s disease and traumatic brain injury. Our assays enable early detection before symptoms appear, providing valuable information from the drug development phase up to clinical practice, to improve the life of patients.
Upcoming events
All events-
0712 '22
Emerging Applications of Microbes (2nd edition)
Event by: VIB -
1212 '22
Type 2 Immunity in Homeostasis and Disease (2nd edition)
Event by: VIB -
2911 '22
BioFIT 2022
Event by: Eurasanté
Latest news
More news-
Indigo Diabetes announces first participant enrolled in the SHINE clinical trial
19 hours ago
Read more
-
FINTEPLA®▼ (fenfluramine) approved in Japan for the treatment of seizures associated with Dravet syndrome
Tuesday September 27th 2022
Read more
-
Pauwels Consulting takes over Science@Work
Friday September 23rd 2022
Read more